AZN vs SRRK · P/E 28, $288.38B cap vs $3.42B cap
AstraZeneca PLC (AZN) versus Scholar Rock Holding Corp (SRRK) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Scholar Rock Holding Corp (SRRK) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported SRRK revenue for 2026-06-30 was $0. Net income was -$215.4M. SRRK currently screens at market cap $3.42B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SRRK currently screens at market cap $3.42B.
Not investment advice. Open the AZN and SRRK stock pages for the full models.
Not investment advice.